Those BRCA Patents

Myriad Settles BRCA Patent Case with Quest; Only GeneDx Lawsuit Remains Feb. 9, 2015 NEW YORK (GenomeWeb) – Quest Diagnostics and Myriad Genetics have settled their patent dispute related to BRCA testing. Myriad along with its co-patent holders and Quest… Continue Reading